Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Medsien
AddedFeb 15, 2024
UpdatedJun 18, 2026
Medsien

Medsien

Seed

Medsien: A trusted leader in scalable remote care management technology for quality patient care.

HQ
Cacheu Region, GW
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize patient care, Medsien is a leading provider of scalable remote care management solutions powered by artificial intelligence. The company focuses on enhancing the quality of patient experiences through advanced technology, offering services that integrate various care management programs, including Chronic Care Management (CCM). Medsien serves a diverse range of healthcare organizations, providing them with tools to efficiently manage patient care remotely.

Notable for its innovative use of Generative AI, Medsien has garnered trust from hundreds of organizations. The company's technology has significantly impacted the healthcare sector by improving patient outcomes and streamlining care processes. Medsien's achievements include widespread adoption of its solutions and recognition as a leader in remote care management technology. The organization continues to set new standards in the industry, demonstrating substantial influence and commitment to quality patient care.

Medsien - Similar Companies

MedM logo

MedM

medm.com

Medsense Health logo

Medsense Health

medsense.health

HealthSnap logo

HealthSnap

Remote Care Partners logo

Remote Care Partners

Healtharc logo

Healtharc

healtharc.io

Medically Home logo

Medically Home

Cadence logo

Cadence

cadence.care

Medisafe logo

Medisafe

medisafe.com

SynsorMed logo

SynsorMed

synsormed.com

GenieMD logo

GenieMD

geniemd.com

Seremedi logo

Seremedi

seremedi.com

CareMax logo

CareMax

caremax.net

care.ai logo

care.ai

care.ai

ChartSpan Medical Technologies logo

ChartSpan Medical Technologies

chartspan.com

Medifies logo

Medifies

medifies.com

Medsien - Quick Facts

Who are Medsien's competitors?

Companies similar to Medsien include MedM, Medsense Health, HealthSnap and Remote Care Partners.

When was Medsien founded?

Medsien was founded in 2018.

Where is Medsien's headquarters located?

Medsien's headquarters is located in Cacheu Region, GW.

When was Medsien's last funding round?

Medsien's most recent funding round was for $4.3M (USD) in June 2022.

How much has Medsien raised to-date?

As of Jun 21, 2022, Medsien has raised a total of $5.3M (USD).

How many employees does Medsien have?

Medsien has 75 employees as of Feb 5, 2024.

Medsien - Classification

Ownership
  • Private
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Healthcare Software
  • Patient Care
  • Remote Care Management
Tags
  • AI
  • Healthcare
  • Healthtech
  • SaaS
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software
Show 10 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7371Computer Programming Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified